enow.com Web Search

  1. Ad

    related to: regeneron approved drugs

Search results

  1. Results from the WOW.Com Content Network
  2. Regeneron Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Regeneron_Pharmaceuticals

    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...

  3. Casirivimab/imdevimab - Wikipedia

    en.wikipedia.org/wiki/Casirivimab/imdevimab

    On 2 October 2020, Regeneron Pharmaceuticals announced that then-US President Donald Trump had received "a single 8 gram dose of REGN-COV2" after testing positive for SARS-CoV-2. [26] [27] The drug was provided by the company in response to a "compassionate use" (temporary authorization for use) request from the president's physicians. [26]

  4. 3 Drugs Approved, but Only 1 Matters - AOL

    www.aol.com/news/2012-08-06-3-drugs-approved-but...

    Regeneron Pharmaceuticals (NAS: REGN) has gained Food and Drug Administration approval of its third drug, Zaltrap, which treats metastatic colorectal cancer. Three approvals in four years is no ...

  5. US FDA approves Dupixent to treat younger kids with ... - AOL

    www.aol.com/news/us-fda-approves-dupixent-treat...

    (Reuters) -The U.S. health regulator has approved the use of Regeneron and Sanofi's Dupixent to treat an allergic inflammation of the esophagus in children aged one to 11 years old and weighing at ...

  6. Atoltivimab/maftivimab/odesivimab - Wikipedia

    en.wikipedia.org/wiki/Atoltivimab/maftivimab/...

    The FDA granted the approval of Inmazeb to Regeneron Pharmaceuticals with an indication for the treatment of infection caused by Zaire ebolavirus in October 2020. [2] [6] The drug has also received orphan drug designation from the European Medicines Agency. [23]

  7. US FDA approves Regeneron's ultra-rare blood disease drug - AOL

    www.aol.com/news/us-fda-approves-regenerons...

    By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare blood disease. The drug pozelimab, branded as Veopoz, would treat ...

  8. Regeneron's Eylea could return to growth after nod to high ...

    www.aol.com/news/regenerons-eylea-could-return...

    A longer dosing gap for the drug could help Regeneron take on rival Roche's Vabysmo and also help soften the blow from incoming cheaper copycat drugs, analysts said. Shares of Regeneron rose 1.7% ...

  9. Odronextamab - Wikipedia

    en.wikipedia.org/wiki/Odronextamab

    [1] [2] It was developed by Regeneron Pharmaceuticals. [1] The most common side effects include cytokine release syndrome, infections, neutropenia, pyrexia (fever), anemia, thrombocytopenia, and diarrhea. [1] Odronextamab was approved for medical use in the European Union in August 2024. [1] [2]

  1. Ad

    related to: regeneron approved drugs